Shunichi Miyakoshi - Concepedia

Author

Shunichi Miyakoshi

Also Known As

SHUN-ICHI MIYAKOSHI, SHUNICHI MIYAKOSHI, Shun-ichi Miyakoshi, Shunichi MIYAKOSHI, Shunichi Miyakoshi, Shun‐ichi Miyakoshi

Publications

712

Citations

H-Index

Concepts

All Affiliations

Daiichi-Sankyo (Japan)Daiichi Sankyo (Germany)Biomedical Research Laboratories (United States)National Institute of Technology, Gunma College Discovery Laboratories (United States)

About

Shunichi Miyakoshi is an author at Daiichi-Sankyo (Japan) specializing in medicine, microbiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	400
2	Biochemistry	6	6	214
3	Natural Sciences	4	4	96
4	Engineering	1	1	13
5	Health Sciences	1	1	19

Shunichi Miyakoshi

Publications

683

Citations

H-Index

Page 1

	Year	Citations
Purification and characterization of cytochrome <i>P</i>‐450<sub>sca</sub> from <i>Streptomyces carbophilus</i> Tatsuji Matsuoka, Shunichi Miyakoshi, Kazuhiko Tanzawa, European Journal of Biochemistry Pravastatin SodiumBiotransformationCellular EnzymologyBiochemistryAldo-keto Reductase	1989	104
Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin Hitoshi Hotoda, Miyuki Furukawa, Makiko Daigo, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ChemistryAzepan-2-one MoietyMedicineAntibacterial Agent	2003	60
Fluconazole Treatment Is Effective against a <i>Candida albicans erg3/erg3</i> Mutant In Vivo Despite In Vitro Resistance Taiga Miyazaki, Yoshitsugu Miyazaki, Koichi Izumikawa, Antimicrobial Agents and Chemotherapy	2006	51
Structure–activity relationships of globomycin analogues as antibiotics Toshihiro Kiho, Mizuka Nakayama, Kayo Yasuda, Bioorganic & Medicinal Chemistry Medicinal ChemistryAntimicrobial Drug DiscoveryMedicineAntimicrobial ChemotherapyAntimicrobial Pharmacokinetics	2003	49
Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds Hitoshi Hotoda, Makiko Daigo, Miyuki Furukawa, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ChemistryBioorganic ChemistryDerivativesNatural Sciences	2003	42
A-102395, a New Inhibitor of Bacterial Translocase I, Produced by Amycolatopsis sp. SANK 60206 Ryo Murakami, Yoko Fujita, Masaaki Kizuka, The Journal of Antibiotics BiochemistryMedicineBacteriologyBiotechnologyBacterial Translocase	2007	36
Studies on Novel Bacterial Translocase I Inhibitors, A-500359s. III. Deaminocaprolactam Derivatives of Capuramycin: A-500359 E, F, H, M-1 and M-2. Yasunori Muramatsu, Shunichi Miyakoshi, Yasumasa Ogawa, The Journal of Antibiotics	2003	36
Synthesis and antimicrobial activity of novel globomycin analogues Toshihiro Kiho, Mizuka Nakayama, Kayo Yasuda, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineNovel Globomycin AnaloguesAntibacterial AgentAntimicrobial Chemotherapy	2003	30
A-94964, a Novel Inhibitor of Bacterial Translocase I, Produced by Streptomyces sp. SANK 60404 Ryo Murakami, Yoko Fujita, Masaaki Kizuka, The Journal of Antibiotics Antimicrobial Drug DiscoveryBacteriologyStreptomyces SpAntibacterial AgentBacterial Translocase	2008	29
Studies on Novel Bacterial Translocase I Inhibitors, A-500359s. IV. Biosynthesis of A-500359s. Takashi Ohnuki, Yasunori Muramatsu, Shunichi Miyakoshi, The Journal of Antibiotics	2003	29

Page 1